Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Study highlights poor clinical utility of germline testing in cancer patients of African ancestry

New research in the March 2023 issue of JNCCN - Journal of the National Comprehensive Cancer Network highlights how the lack of genomic research for people with African ancestry, particularly those from the Sub-Saharan region, is hampering efforts to reduce disparities for people with cancer.

10 Mar 2023

Hospitalist comanagement associated with shorter length of hospital stay for cancer patients

Involving hospitalists in the co-management of care for patients with cancer is associated with decreased length of hospital stay for patients, increased inpatient hospital capacity, and reduced stress among oncologists – all while maintaining high-quality inpatient care, according to a new study from Yale Cancer Center and Smilow Cancer Hospital.

10 Mar 2023

Cancer stage and receptor status influence the risk of breast cancer recurrence

New research indicates that for patients with breast cancer, the cancer’s stage and receptor status can help clinicians predict whether and when cancer might recur after initial treatment.

9 Mar 2023

Multidisciplinary clinic uses neuropsychology to improve quality of life for cancer patients

Ken Kessler’s apparent depression and confusion were getting worse.

9 Mar 2023

Detection and targeting of splicing deregulation reveal a potential strategy for pAML therapy

Pediatric acute myeloid leukemia or pAML is a childhood blood cancer, one that has proved confounding to clinicians and researchers, with a high relapse rate and relatively few identified genetic mutations (compared to the adult version) that might explain its cause.

8 Mar 2023

Breakthrough drug works against all the main types of primary bone cancer

Researchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer.

8 Mar 2023

Yale Cancer Center receives funding to increase access to early phase clinical trials

Yale Cancer Center is pleased to announce collaborative funding to support and increase access to early phase clinical trials for patients at community sites for cancer care in Connecticut.

6 Mar 2023

Yale scientists seek to identify optimal sequential treatments for advanced cancer

A team of Yale scientists seeks to determine which treatment sequences produce the best results for people with advanced cancer while examining the cost of these treatments.

6 Mar 2023

Tumors' response to hormone therapy may be a biomarker for personalization of breast radiotherapy

How estrogen receptor-positive (ER+) breast cancer responds to hormone therapy may hold keys to understanding how it will respond to radiation therapy, and an experimental drug that increases the effectiveness of hormone therapy also overcomes radiation resistance in breast cancer, a study by UT Southwestern Medical Center researchers shows.

6 Mar 2023

BioInfect: Bringing the best brains to the challenge of antimicrobial resistance

During the conference, we had the chance to catch up with some of the speakers to ask them about their work, as well as what they would be discussing at the 2023 BioInfet Conference.

6 Mar 2023

New way to carry drugs across the blood-brain barrier using nanoparticles

Brain tumors are notoriously hard to treat. One reason is the challenge posed by the blood-brain barrier, a network of blood vessels and tissue with closely spaced cells.

3 Mar 2023

Research identifies a possible treatment strategy for rare bone marrow failure syndrome

Bone marrow is the spongy tissue inside bone responsible for making red blood cells, white blood cells and platelets. Bone marrow failure syndromes lead to an increased risk of developing dangerous infections, anemia and an increased risk of blood cancers.

2 Mar 2023

AI model accurately predicts cancer patient survival with more readily available doctor's notes

A team of researchers from the University of British Columbia and BC Cancer have developed an artificial intelligence (AI) model that predicts cancer patient survival more accurately and with more readily available data than previous tools.

2 Mar 2023

Starting immunotherapy before surgery improves the outlook for patients with stage III-IV melanoma

Patients with high-risk melanoma who received the immunotherapy drug pembrolizumab both before and after surgery to remove cancerous tissue had a significantly lower risk of their cancer recurring than similar patients who received the drug only after surgery.

1 Mar 2023

Oncology News and Research

Further Reading

Study highlights poor clinical utility of germline testing in cancer patients of African ancestry

Hospitalist comanagement associated with shorter length of hospital stay for cancer patients

Cancer stage and receptor status influence the risk of breast cancer recurrence

Multidisciplinary clinic uses neuropsychology to improve quality of life for cancer patients

Detection and targeting of splicing deregulation reveal a potential strategy for pAML therapy

Breakthrough drug works against all the main types of primary bone cancer

Yale Cancer Center receives funding to increase access to early phase clinical trials

Yale scientists seek to identify optimal sequential treatments for advanced cancer

Tumors' response to hormone therapy may be a biomarker for personalization of breast radiotherapy

BioInfect: Bringing the best brains to the challenge of antimicrobial resistance

New way to carry drugs across the blood-brain barrier using nanoparticles

Research identifies a possible treatment strategy for rare bone marrow failure syndrome

AI model accurately predicts cancer patient survival with more readily available doctor's notes

Starting immunotherapy before surgery improves the outlook for patients with stage III-IV melanoma

What are the clinical considerations of proton radiotherapy for individuals with locally advancing breast cancer?

New imaging method could help make better decisions on personalized cancer treatment

Product development and drug delivery at Seda

New insight on the uptick in colorectal cancer diagnoses and deaths among younger people

New funding to accelerate development of potential anti-cancer compound into the clinic

Growing use of immunotherapy linked to increase in Medicare spending for outpatient terminal cancer care

Event guide: The 9th DDR Inhibitors Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News